Repligen Corporation

Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)